The ATTAIN-1 trial reported a mean change in body weight at 72 weeks of -11.2% with the highest dose of orforglipron 36 mg compared to -2.1% with placebo in adults with obesity or overweight and at least one weight-related comorbidity
Disclosure: Im a paid contributor to NutritionNC.com and was not compensated by Polly for this review
According to a comprehensive aggregation of all the scientific data on BPC-157 to date, the following benefits have been observed in rats [2]: Exerts protective effects during damaging surgical procedures or administration of a toxic substance Heals organ, bone, and joint damage Treats stomach ulcers Possesses anti-inflammatory properties While the side effects of BPC-157 appear to be non-existent, very little research involving human test subjects exists [3]: While BPC-157 is not approved by the FDA, it can be purchased by researchers and, in rare cases, can be prescribed by a doctor in certain circumstances
It is a once-daily weight loss pill manufactured by Eli Lilly that received FDA approval on April 1, 2026
1 / 7 The GLP-1 Diet Cookbook ($20) Maintaining optimal nutrition can be difficult on GLP-1 medications